The ‘908 patent dramatically strengthens ThermoLife’s ingredient portfolio. ThermoLife will only enter into licensing agreements with companies that have a proven record of making quality products and following FDA regulations.
Phoenix, AZ (PRWEB) June 19, 2012
ThermoLife International, LLC (ThermoLife) announced today that the United States Patent and Trademark Office (USPTO) issued U.S. Patent No. 8,202,908 (the ‘908 patent) for ThermoLife’s novel use of D-Aspartic acid (DAA). The patented method uses a DAA compound to increase the levels of testosterone, growth hormone, and/or insulin-like growth factor 1 in adult males. The potential benefits of DAA are astounding and the patented method will transform testosterone boosting dietary supplements and methods.
ThermoLife has a long history of developing innovative and proven products and processes. With the addition of the ‘908 patent, ThermoLife has been awarded seven patents covering more than 20 various compounds and methods of use, and still has many pending applications in the pipeline and new technologies at various stages of development.
These patents protect ThermoLife’s innovative and proven products and methods, as well as validate ThermoLife’s market leadership in new dietary ingredient research. These patents also allow ThermoLife to continue building confidence with its licensing partners and give consumers and companies that work with ThermoLife assurance that they are buying one-of-a-kind products that they cannot get elsewhere.
About Thermolife
Founded in 1998, ThermoLife is dedicated to developing real products and methods that work. ThermoLife is a leading manufacturer in the sports nutrition and supplement industry. ThermoLife is committed to developing only the purest, most effective, and innovative products. For more information about ThermoLife and its patents, or to license any of ThermoLife’s patented ingredients contact Ron Kramer at Ron(at)ThermoLife(dot)com
We're here to help.
Call 1-866-640-6397
©Copyright 1997-, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.
